SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950168-02-003424
Filing Date
2002-11-14
Accepted
2002-11-14 16:36:42
Documents
7
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 204731
3 DR. FALK PHARMA LICENCE AGREEMENT dex1032.htm EX-10.32 272733
4 LOAN AND SECURITY AGREEMENT dex1033.htm EX-10.33 231117
5 COMMERCIAL PROMISSORY NOTE dex1034.htm EX-10.34 30953
6 NEGATIVE PLEDGE AGREEMENT dex1035.htm EX-10.35 27710
7 CERTIFICATION dex991.htm EX-99.1 2290
8 CERTIFICATION dex992.htm EX-99.2 3036
  Complete submission text file 0000950168-02-003424.txt   774885
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 02825434
SIC: 2834 Pharmaceutical Preparations